Lumito
0.477
SEK
-3.25 %
Less than 1K followers
LUMITO
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-3.25%
-8.27%
-17.9%
-20.63%
-45.05%
-64.93%
-49.58%
-84.69%
-63.99%
Lumito specializes in medical technology for digital pathology. The company strives to improve tissue diagnostics with its patented technology based on upconverted nanoparticles. The company plans to initially launch its first product for research laboratories. The company was formed in 2010 as a spinoff from a research group at Lund University's Department of Atomic Physics and Laser Center. Lumito has its headquarters in Lund.
Read moreMarket cap
126.83M SEK
Turnover
373.58K SEK
Revenue
100K
EBIT %
-38,300 %
P/E
-
Dividend yield-%
-
Financial calendar
7/5
2025
General meeting '25
7/5
2025
Interim report Q1'25
22/8
2025
Interim report Q2'25
All
Press releases
3rd party
ShowingAll content types
Lumito and Concept Life Sciences join forces to advance tissue analysis in drug discovery
Lumitos styrelsen och ledningsgruppen har ökat sitt aktieinnhav
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools